# Assessment of Quizartinib Pharmacokinetic in Subjects With Severe Hepatic Impairment

> **NCT06740799** · PHASE1 · RECRUITING · sponsor: **Daiichi Sankyo** · enrollment: 12 (estimated)

## Conditions studied

- Hepatic Impairment

## Interventions

- **DRUG:** Quizartinib

## Key facts

- **NCT ID:** NCT06740799
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-30
- **Primary completion:** 2026-10-31
- **Final completion:** 2026-10-31
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06740799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06740799, "Assessment of Quizartinib Pharmacokinetic in Subjects With Severe Hepatic Impairment". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06740799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*